|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $38,751,601 | $29,837,633 | $40,675,410 | $56,355,494 | $39,501,747 | $46,931,392 | $31,025,102 |
| Streptomycins & their derivs.; salts thereof | $13,027,097 | $22,752,777 | $33,007,373 | $3,525,320 | $1,473,701 | $3,710,324 | $2,068,365 |
| Tetracyclines & their derivs.; salts thereof | $14,044,505 | $8,980,010 | $7,976,900 | $2,133,548 | $6,935,011 | $11,746,809 | $8,012,663 |
| Chloramphenicol & its derivs.; salts thereof | $108,745 | $777,003 | $247,620 | $160,193 | $42,380 | $794,307 | $1,871,459 |
| Erythromycin & its derivs.; salts thereof | $529,669,188 | $413,553,656 | $339,091,746 | $446,586,392 | $365,227,767 | $408,510,092 | $526,834,393 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $769,056,361 | $720,608,621 | $982,272,679 | $739,501,058 | $328,880,026 | $341,125,574 | $434,437,092 |
| Total | $1,364,657,497 | $1,196,509,700 | $1,403,271,728 | $1,248,262,005 | $742,060,632 | $812,818,498 | $1,004,249,074 |
|
|
